Press ReleaseGENEIII Sets the Global Benchmark for Ergothioneine with Pharmaceutical-Grade Purity and Human Clinical Validation SINGAPORE, Jan. 20, 2026 /PRNewswire/ — On January 9th, GENEIII reaffirmed its global…CISION PRNewswireJanuary 20, 2026
Press ReleaseFITUR 2026 brings together global tourism with more than 160 countries and 10,000 companies Mexico joins FITUR 2026 as Partner Country in an edition bringing together…CISION PRNewswireJanuary 20, 2026
ZTO Express Holds 2026 National Network Conference SHANGHAI, Jan. 20, 2026 /PRNewswire/ — On January 20, 2026, ZTO Express (Cayman)…CISION PRNewswireJanuary 20, 2026
Press ReleaseBybit Explores 2026 Macro Volatility and Always-On Market Access DUBAI, UAE, Jan. 20, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…CISION PRNewswireJanuary 20, 2026
Press ReleaseBuilding the Run: Xtep Charts a New Community Ecosystem in Southeast Asia JAKARTA, Indonesia and KUALA LUMPUR, Malaysia, Jan. 20, 2026 /PRNewswire/ — Global performance…CISION PRNewswireJanuary 20, 2026
Multilingual AI Voice Agent was launched by Zadarma LONDON, Jan. 20, 2026 /PRNewswire/ — Zadarma, a global VoIP service provider,…CISION PRNewswireJanuary 20, 2026
Press ReleaseAI/works™ heralds a new era of Agile and next-generation software development Thoughtworks’ agentic development platform developed to support both technology modernization and greenfield…CISION PRNewswireJanuary 20, 2026
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development – In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37…CISION PRNewswireJanuary 20, 2026